Clobazam Trials for Dravet Syndrome - Pharma, Regulators, and Advocates Working Togethert скачать в хорошем качестве

Clobazam Trials for Dravet Syndrome - Pharma, Regulators, and Advocates Working Togethert

At the Pediatric Clinical Trials Conference recently held in Philadelphia PA, Deborah Lee, MD, PhD, Senior Medical Director at Lundbeck talked about their experience developing clinical trials to test the safety and efficacy of Clobazam in children with Dravet syndrome. In this exclusive interview with Rare Disease Report, Dr Lee summarizes her presentation that showcased the importance of working with the FDA to create clinical trials that have a better chance of getting a drug approved. Clobazam is currently approved for Lennox Gastaut syndrome and is in clinical trials for Dravet syndrome. For more information, visit www.lundbeck.com